CSF2 and juvenile myelomonocytic leukemia: A hallmark of JMML is a hypersensitivity to granulocyte macrophage-colony stimulating factor (GM-CSF), which leads to enhanced in vitro proliferation of monocyte-macrophage colonies in the absence of exogenous colony stimulating factor [3, 4].